GENOVESE, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 6.650
EU - Europa 6.339
AS - Asia 6.332
SA - Sud America 862
AF - Africa 167
OC - Oceania 78
Continente sconosciuto - Info sul continente non disponibili 9
Totale 20.437
Nazione #
US - Stati Uniti d'America 6.289
CN - Cina 1.775
IT - Italia 1.617
SG - Singapore 1.515
GB - Regno Unito 1.132
BR - Brasile 606
DE - Germania 530
HK - Hong Kong 499
FR - Francia 451
ES - Italia 437
RU - Federazione Russa 435
VN - Vietnam 373
IN - India 369
SE - Svezia 368
BD - Bangladesh 366
TR - Turchia 363
JP - Giappone 352
CA - Canada 230
IE - Irlanda 198
ID - Indonesia 181
NL - Olanda 174
DK - Danimarca 169
FI - Finlandia 159
KR - Corea 118
CH - Svizzera 106
BE - Belgio 101
AR - Argentina 78
MX - Messico 74
AT - Austria 71
PL - Polonia 71
CO - Colombia 66
AU - Australia 64
TW - Taiwan 55
TH - Thailandia 53
GR - Grecia 52
PH - Filippine 49
PT - Portogallo 47
IR - Iran 45
RO - Romania 44
CL - Cile 43
UA - Ucraina 38
SA - Arabia Saudita 35
CI - Costa d'Avorio 31
EG - Egitto 25
HU - Ungheria 25
ZA - Sudafrica 24
IL - Israele 22
IQ - Iraq 21
EC - Ecuador 20
MY - Malesia 20
AE - Emirati Arabi Uniti 19
CZ - Repubblica Ceca 18
MA - Marocco 17
SK - Slovacchia (Repubblica Slovacca) 16
KE - Kenya 14
PK - Pakistan 14
UZ - Uzbekistan 14
VE - Venezuela 14
PE - Perù 13
CR - Costa Rica 12
DZ - Algeria 12
NZ - Nuova Zelanda 12
TN - Tunisia 12
SI - Slovenia 11
HR - Croazia 10
LT - Lituania 9
LU - Lussemburgo 9
GD - Grenada 8
LB - Libano 8
NO - Norvegia 8
BH - Bahrain 7
GE - Georgia 7
JO - Giordania 7
PY - Paraguay 7
UY - Uruguay 7
AZ - Azerbaigian 6
JM - Giamaica 6
PR - Porto Rico 6
AP - ???statistics.table.value.countryCode.AP??? 5
BG - Bulgaria 5
BO - Bolivia 5
BY - Bielorussia 5
LY - Libia 5
NP - Nepal 5
PS - Palestinian Territory 5
RS - Serbia 5
SC - Seychelles 5
CY - Cipro 4
DO - Repubblica Dominicana 4
EE - Estonia 4
ET - Etiopia 4
MD - Moldavia 4
MO - Macao, regione amministrativa speciale della Cina 4
NG - Nigeria 4
PA - Panama 4
SV - El Salvador 4
EU - Europa 3
KG - Kirghizistan 3
KZ - Kazakistan 3
ME - Montenegro 3
Totale 20.382
Città #
Singapore 892
Southend 667
Ashburn 623
Milan 467
Hong Kong 388
Chandler 370
San Jose 298
Fairfield 293
Beijing 242
Council Bluffs 238
New York 217
Dallas 206
Ann Arbor 196
Dublin 187
Princeton 165
Wilmington 162
Los Angeles 156
Santa Clara 153
Tokyo 152
Houston 148
Redwood City 142
Madrid 138
Seattle 136
Frankfurt am Main 130
Helsinki 128
Jakarta 123
Woodbridge 123
Istanbul 116
Guangzhou 110
Cambridge 94
São Paulo 94
Lauterbourg 93
Hanoi 89
Shanghai 86
Ho Chi Minh City 84
London 84
Rome 84
Bengaluru 82
Buffalo 79
Hefei 72
Des Moines 68
Nanjing 68
Barcelona 66
Central 66
Moscow 66
Hangzhou 61
Brussels 60
Ankara 59
Dearborn 56
Paris 56
Boardman 55
Toronto 52
Chicago 47
Atlanta 45
Mumbai 44
Rio de Janeiro 44
Seoul 44
Zurich 44
Hamburg 43
Montreal 43
Amsterdam 42
Dong Ket 42
Munich 41
Vienna 40
Berlin 39
Jinan 39
Phoenix 39
Taipei 38
Tianjin 38
Florence 36
San Diego 35
Brooklyn 34
Chennai 33
Washington 33
Cangzhou 32
Valencia 32
Abidjan 31
Bologna 31
Duncan 31
Naples 31
Shenzhen 31
Medellín 30
Changsha 28
Izmir 28
Nuremberg 28
San Francisco 28
Athens 27
Ottawa 27
Shenyang 27
Buenos Aires 26
Turin 26
Campinas 25
Chengdu 25
Manchester 25
Warsaw 25
Columbus 24
New Delhi 24
Trieste 23
Jeddah 22
Perugia 22
Totale 10.632
Nome #
Evidence for a “window of opportunity” in hidradenitis suppurativa treated with adalimumab: a retrospective, real‐life multicenter cohort study 2.961
Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients 1.081
Photobiomodulation as potential novel third line tool for non-invasive treatment of Hidradenitis Suppurativa 693
Lymphocytic variant of hypereosinophilic syndrome presenting with polymorphic cutaneous manifestations and nonspecific histopathological findings 533
Efficacy of a detergent combined with a moisturiser for the treatment of pruritus associated with xerosis in an elderly population affected by Kaposi's sarcoma 428
Clinical and immunopathological features of idiopathic cutaneous IgM/IgG vasculitis versus idiopathic skin-limited IgA vasculitis 416
Late-onset post-mammoplasty pyoderma gangrenosum treated with tobacco-pouch suture combined with oral corticosteroids 357
How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group 350
Linear IgA bullous dermatosis in adults and children: A clinical and immunopathological study of 38 patients 312
Phthiriasis of the eyelashes 293
Clinical Response and Quality of Life in Patients with Severe Atopic Dermatitis Treated with Dupilumab : A Single-Center Real-Life Experience 281
Hidradenitis suppurativa and adalimumab in the COVID-19 era 277
Paradoxical Skin Reactions to Biologics in Patients With Rheumatologic Disorders 273
Skin Manifestations Associated with COVID-19 : Current Knowledge and Future Perspectives 273
Refractory disseminated superficial actinic porokeratosis effectively treated with cholesterol/lovastatin cream: a case report 260
Post-surgical thyroid bed pyoderma gangrenosum mimicking recurrent papillary thyroid carcinoma 240
A Systematic Review of Treatment Options and Clinical Outcomes in Pemphigoid Gestationis 239
Hidradenitis suppurativa: the "bright side" of autoinflammation and hidden diseases 235
Outbreak of chilblain-like acral lesions in children in the metropolitan area of Milan, Italy, during the COVID-19 pandemic 235
Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients 234
Italian guidelines for the diagnosis and treatment of classic and iatrogenic Kaposi's sarcoma 228
Dermatological Manifestations in Inflammatory Bowel Diseases 226
Coexistence of Kaposi's sarcoma and psoriasis : is there a hidden relationship? 219
Mechanisms of Inflammation in Neutrophil-Mediated Skin Diseases 213
Cutaneous manifestations in patients with COVID-19 : a preliminary review of an emerging issue 203
New insights into the pathogenesis of bullous pemphigoid : 2019 update 202
Cutaneous metastasis from breast carcinoma clinically mimicking pyogenic granuloma 194
Secondary syphilis masquerading as lupus vulgaris in an HIV-infected patient: A diagnosis suggested by histology 193
Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments 191
Keratosis lichenoides chronica: A case report and focused overview of the literature 186
Clinical and serological predictors of relapse in pemphigus: a study of 143 patients 182
European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology – Part II 181
SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris 174
Urticarial eruption in a patient with intermittent fever and monoclonal IgM gammopathy 174
European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology – Part I 173
SYNDROMIC HIDRADENITIS SUPPURATIVA: GENOTYPE-PHENOTYPE CORRELATION THROUGH WHOLE-EXOME SEQUENCING IN 10 UNRELATED PATIENTS 171
An integrated approach to unravel hidradenitis suppurativa etiopathogenesis 170
Autoimmune bullous diseases in non-HIV Kaposi's sarcoma : a retrospective study in a large cohort of patients 169
Primary syphilis of the neck mimicking a pyodermatitis 166
Case report: A case of anti-laminin 332 mucous membrane pemphigoid associated with severe pharyngolaryngeal involvement 164
PD-L1 expression in tumour microenvironment supports the rationale for immune checkpoint blockade in classic Kaposi's sarcoma 161
Ultrasonographic findings in primary umbilical endometriosis 158
A dermatologic perspective on autoinflammatory diseases 157
Necrobiotic xanthogranuloma in IgG-κ multiple myeloma 156
Lichen planopilaris and dermatitis herpetiformis: a fortuitous association? 155
Skin barrier status during dupilumab treatment in patients with severe atopic dermatitis 155
Oesophagitis dissecans superficialis as the presenting sign oisolated oesophageal mucous membrane pemphigoid 151
Autoimmune bullous diseases during pregnancy : insight into pathogenetic mechanisms and clinical features 150
Eosinophilic Dermatoses: Recognition and Management 150
Five cases of new-onset pemphigus following vaccinations against coronavirus disease 2019 149
Iatrogenic Kaposi's Sarcoma : a Retrospective Cohort Study in an Italian Tertiary Care Centre 149
An ulcer on the lower lip 148
Lichen planus hypertrophicus-inversus occurring in a patient with Bannayan-Riley-Ruvalcaba syndrome 148
Ulcerative injection site reaction after third COVID-19 vaccine dose with mRNA-1273 146
Comment on: Treatment of psoriasis with ustekinumab in a patient with HIV-related Kaposi sarcoma 146
Chronic spontaneous urticaria in clinical practice: a pilot survey about attitudes and perceptions on assessment, diagnostic work-up and dietary management 143
Clinical, genetic, and ultrasonographic features of periumbilical perforating pseudoxanthoma elasticum 142
Varicella-like exanthem associated with COVID-19 in an 8-year-old girl : a diagnostic clue? 141
Aberrant breast tissue in complete androgen insensitivity syndrome 138
Multisystem Inflammatory Syndrome in Children Associated with COVID-19: A Review with an Emphasis on Mucocutaneous and Kawasaki Disease-Like Findings 133
Acetaminophen-induced generalized fixed drug eruption in a 5-year-old girl 132
The clinical spectrum of COVID-19-associated cutaneous manifestations: an Italian multicentre study of 200 adult patients 132
SARS-CoV-2 Detection by Digital Polymerase Chain Reaction and Immunohistochemistry in Skin Biopsies from 52 Patients with Different COVID-19-Associated Cutaneous Phenotypes 131
A sweet fever 130
Pustular psoriasis : from pathophysiology to treatment 127
Bullous pemphigoid associated with COVID-19 vaccines : An Italian multicentre study 127
Clinical and laboratory features of 244 men with primary syphilis: a 5-year single-centre retrospective study 124
Multiple nodules on the scrotal wall 124
Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review 119
25-Hydroxyvitamin D serum levels inversely correlate to disease severity and serum C-reactive protein levels in patients with hidradenitis suppurativa 119
Dermal Amyloid Deposits: A Possible Misleading Pathologic Finding 118
Ultrasonographic intraoperative monitoring and follow-up of Kaposi's sarcoma nodules under treatment with intralesional vincristine 117
Therapeutic management of chronic spontaneous urticaria in clinical practice: results from a pilot survey 117
Brunsting-Perry pemphigoid: a systematic review 115
Urticarial vasculitis: Clinical and laboratory findings with a particular emphasis on differential diagnosis 113
The Intriguing Links between Psoriasis and Bullous Pemphigoid 111
Pyoderma gangrenosum-like ulcerations in granulomatosis with polyangiitis : two cases and literature review 111
Successful treatment of co-existent SAPHO syndrome and hidradenitis suppurativa with adalimumab and methotrexate 110
Imatinib-induced pyoderma gangrenosum in a patient with chronic myeloid leukemia 106
Clinical and histopathologic study of 39 patients with imported tungiasis 105
Rosacea-like cutaneous localization of small lymphocytic lymphoma unmasked by high-frequency-ultrasound 103
Venous Thromboembolism in Chronic Inflammatory Skin Diseases-The Need to Consider Bullous Pemphigoid 103
Baseline D-dimer plasma levels correlate with disease activity but not with the response to omalizumab in chronic spontaneous urticaria 102
Cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: a real-life multicentre experience 102
Eruptive pyogenic granulomas following coronavirus disease 2019 101
Case of a severe vulgaris and foliaceus pemphigus in a young patient treated with rituximab, with subsequent development of chronic urticaria 100
Tinea corporis caused by Trichophyton equinum in a rider and review of the literature 99
Treatment of Autoimmune Bullous Diseases During Pregnancy and Lactation : A Review Focusing on Pemphigus and Pemphigoid Gestationis 97
Genetic screening in new onset inflammatory bowel disease during anti-interleukin 17 therapy: unmet needs and call for action 95
Bullous erythroderma: novel association of pityriasis rubra pilaris with bullous pemphigoid 92
Response to "Reply to 'Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients': To consider varicella-like exanthem associated with COVID-19, virus varicella zoster and virus herpes simplex must be ruled out" 91
Altered keratinization and vitamin D metabolism may be key pathogenetic pathways in syndromic hidradenitis suppurativa: a novel whole exome sequencing approach 90
Reply to “New-onset bullous pemphigoid after inactivated Covid-19 vaccine: Synergistic effect of the Covid-19 vaccine and vildagliptin” 87
Ultraviolet A phototest positivity is associated with higher free erythrocyte protoporphyrin IX concentration and lower transferrin saturation values in erythropoietic protoporphyria 86
Daylight methyl-aminolevulinate photodynamic therapy versus ingenol mebutate for the treatment of actinic keratoses : an intraindividual comparative analysis 82
Follicular larva migrans 81
Idiopathic chilblains in myelomonocytic leukemia : not a simple association 78
Miescher nevus as devil's mark, but also as beauty mark 76
Gliptin-associated bullous pemphigoid shows peculiar features of anti-BP180 and -BP230 humoral response: Results of a multicenter study 76
PASH, PAPASH, PsAPASH, and PASS: The autoinflammatory syndromes of hidradenitis suppurativa 73
Totale 20.928
Categoria #
all - tutte 56.981
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.981


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021315 0 0 0 0 0 0 0 0 0 0 0 315
2021/20222.506 144 205 233 190 190 216 187 222 236 184 169 330
2022/20232.461 256 198 165 215 238 324 147 193 216 134 249 126
2023/20242.291 163 180 184 186 315 191 166 146 122 159 217 262
2024/20253.626 197 385 174 308 318 215 133 348 250 280 346 672
2025/20266.720 607 422 616 612 604 404 703 379 819 495 860 199
Totale 21.167